 Virginia Ferguson
Concepts (458)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cartilage, Articular | 13 | 2024 | 311 | 3.690 |
Why?
| | Bone and Bones | 13 | 2020 | 317 | 2.460 |
Why?
| | Space Flight | 18 | 2021 | 87 | 2.190 |
Why?
| | Weightlessness | 11 | 2021 | 45 | 2.020 |
Why?
| | Growth Plate | 3 | 2022 | 36 | 1.510 |
Why?
| | Osteocytes | 6 | 2022 | 28 | 1.400 |
Why?
| | Aging | 9 | 2025 | 1864 | 1.340 |
Why?
| | Biomechanical Phenomena | 20 | 2025 | 810 | 1.320 |
Why?
| | Tissue Scaffolds | 4 | 2024 | 211 | 1.280 |
Why?
| | Finite Element Analysis | 11 | 2024 | 75 | 1.270 |
Why?
| | Hindlimb Suspension | 8 | 2013 | 20 | 1.260 |
Why?
| | Hydrogels | 9 | 2024 | 678 | 1.210 |
Why?
| | Ligaments | 3 | 2025 | 60 | 1.190 |
Why?
| | Bone Remodeling | 6 | 2021 | 75 | 1.190 |
Why?
| | Tensile Strength | 4 | 2025 | 97 | 1.180 |
Why?
| | Polyethylene Glycols | 7 | 2024 | 641 | 1.170 |
Why?
| | Sacrum | 2 | 2025 | 67 | 1.130 |
Why?
| | Collagen | 8 | 2024 | 452 | 1.060 |
Why?
| | Mechanical Phenomena | 5 | 2024 | 84 | 1.040 |
Why?
| | Cortical Bone | 4 | 2020 | 18 | 1.010 |
Why?
| | Muscular Atrophy | 5 | 2020 | 86 | 1.000 |
Why?
| | Calcification, Physiologic | 9 | 2020 | 32 | 0.990 |
Why?
| | Bone Diseases, Metabolic | 4 | 2021 | 63 | 0.990 |
Why?
| | Osteoarthritis | 3 | 2016 | 185 | 0.950 |
Why?
| | Animals | 73 | 2025 | 36940 | 0.930 |
Why?
| | Cartilage | 4 | 2022 | 188 | 0.920 |
Why?
| | Delivery, Obstetric | 1 | 2025 | 144 | 0.870 |
Why?
| | Splenic Artery | 4 | 2016 | 14 | 0.860 |
Why?
| | Glycosaminoglycans | 5 | 2021 | 83 | 0.850 |
Why?
| | Mice, Inbred C57BL | 31 | 2025 | 5757 | 0.840 |
Why?
| | Extracellular Matrix | 6 | 2024 | 528 | 0.830 |
Why?
| | Muscle, Skeletal | 11 | 2020 | 1724 | 0.790 |
Why?
| | Umbilical Arteries | 2 | 2013 | 55 | 0.770 |
Why?
| | Postpartum Period | 1 | 2025 | 340 | 0.770 |
Why?
| | Tibia | 10 | 2022 | 178 | 0.760 |
Why?
| | Tissue Engineering | 8 | 2024 | 423 | 0.730 |
Why?
| | Osteoporosis | 3 | 2020 | 243 | 0.720 |
Why?
| | Elasticity | 8 | 2017 | 197 | 0.700 |
Why?
| | Renal Insufficiency, Chronic | 2 | 2019 | 617 | 0.700 |
Why?
| | Sepharose | 2 | 2017 | 34 | 0.650 |
Why?
| | Hindlimb | 4 | 2021 | 128 | 0.640 |
Why?
| | Bone Density | 14 | 2022 | 489 | 0.640 |
Why?
| | Femur | 12 | 2021 | 254 | 0.640 |
Why?
| | Mice | 43 | 2025 | 17787 | 0.640 |
Why?
| | Fractures, Bone | 3 | 2021 | 380 | 0.610 |
Why?
| | Fetal Growth Retardation | 3 | 2013 | 565 | 0.610 |
Why?
| | Physical Conditioning, Animal | 3 | 2010 | 257 | 0.570 |
Why?
| | Vascular Stiffness | 2 | 2013 | 494 | 0.560 |
Why?
| | Models, Theoretical | 2 | 2017 | 578 | 0.510 |
Why?
| | Macrophage Colony-Stimulating Factor | 3 | 2011 | 21 | 0.490 |
Why?
| | Muscle Strength | 3 | 2020 | 317 | 0.490 |
Why?
| | Cancellous Bone | 4 | 2020 | 23 | 0.480 |
Why?
| | Cervix Uteri | 1 | 2015 | 48 | 0.470 |
Why?
| | Water | 2 | 2016 | 460 | 0.450 |
Why?
| | Carotid Arteries | 2 | 2013 | 206 | 0.440 |
Why?
| | Chondrocytes | 1 | 2016 | 212 | 0.440 |
Why?
| | Stress, Mechanical | 7 | 2022 | 485 | 0.430 |
Why?
| | Printing, Three-Dimensional | 4 | 2024 | 95 | 0.420 |
Why?
| | Aorta, Abdominal | 1 | 2013 | 46 | 0.420 |
Why?
| | Pelvic Organ Prolapse | 2 | 2025 | 51 | 0.420 |
Why?
| | Insulin-Like Growth Factor I | 3 | 2013 | 319 | 0.420 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2018 | 752 | 0.410 |
Why?
| | Intervertebral Disc | 1 | 2013 | 39 | 0.410 |
Why?
| | Muscle Fatigue | 2 | 2013 | 102 | 0.410 |
Why?
| | Adaptation, Biological | 1 | 2013 | 56 | 0.400 |
Why?
| | Software | 1 | 2018 | 665 | 0.390 |
Why?
| | Tooth Wear | 1 | 2012 | 20 | 0.380 |
Why?
| | Neurophysiology | 1 | 2012 | 12 | 0.380 |
Why?
| | Dental Enamel | 1 | 2012 | 70 | 0.380 |
Why?
| | Anisotropy | 3 | 2016 | 79 | 0.370 |
Why?
| | Lemur | 1 | 2012 | 52 | 0.370 |
Why?
| | Horses | 2 | 2009 | 111 | 0.360 |
Why?
| | Lumbar Vertebrae | 1 | 2013 | 246 | 0.360 |
Why?
| | Aorta, Thoracic | 1 | 2013 | 267 | 0.360 |
Why?
| | Haversian System | 1 | 2010 | 3 | 0.350 |
Why?
| | Cartilage Diseases | 2 | 2019 | 39 | 0.350 |
Why?
| | Swine | 7 | 2019 | 775 | 0.340 |
Why?
| | Pre-Eclampsia | 1 | 2013 | 190 | 0.340 |
Why?
| | Pregnancy | 8 | 2025 | 6763 | 0.330 |
Why?
| | Porosity | 3 | 2020 | 102 | 0.320 |
Why?
| | Bone Development | 4 | 2004 | 54 | 0.320 |
Why?
| | Electric Stimulation | 2 | 2013 | 264 | 0.310 |
Why?
| | Gene Expression Regulation | 6 | 2019 | 2607 | 0.310 |
Why?
| | Female | 40 | 2025 | 73304 | 0.300 |
Why?
| | Spleen | 5 | 2017 | 514 | 0.300 |
Why?
| | Umbilical Cord | 1 | 2009 | 85 | 0.300 |
Why?
| | Metacarpal Bones | 1 | 2008 | 13 | 0.300 |
Why?
| | Regenerative Medicine | 2 | 2019 | 49 | 0.290 |
Why?
| | Osteogenesis | 2 | 2019 | 188 | 0.280 |
Why?
| | Osteoblasts | 4 | 2020 | 126 | 0.280 |
Why?
| | X-Ray Microtomography | 3 | 2019 | 94 | 0.270 |
Why?
| | Bone Diseases | 2 | 2018 | 62 | 0.270 |
Why?
| | Exercise Test | 2 | 2013 | 625 | 0.270 |
Why?
| | Compressive Strength | 3 | 2019 | 74 | 0.260 |
Why?
| | Thymus Gland | 4 | 2013 | 312 | 0.260 |
Why?
| | Male | 31 | 2021 | 67762 | 0.260 |
Why?
| | Cattle | 3 | 2022 | 984 | 0.250 |
Why?
| | Uterus | 2 | 2024 | 215 | 0.250 |
Why?
| | Recovery of Function | 1 | 2010 | 653 | 0.250 |
Why?
| | Range of Motion, Articular | 1 | 2008 | 393 | 0.250 |
Why?
| | Elastic Modulus | 3 | 2016 | 123 | 0.240 |
Why?
| | Arteries | 3 | 2018 | 269 | 0.240 |
Why?
| | Phantoms, Imaging | 2 | 2018 | 152 | 0.240 |
Why?
| | Microscopy, Confocal | 2 | 2018 | 325 | 0.240 |
Why?
| | RNA Editing | 1 | 2025 | 24 | 0.240 |
Why?
| | Bone Resorption | 4 | 2015 | 86 | 0.240 |
Why?
| | Materials Testing | 4 | 2016 | 356 | 0.240 |
Why?
| | Adenosine Deaminase | 1 | 2025 | 36 | 0.230 |
Why?
| | Haploinsufficiency | 1 | 2025 | 56 | 0.230 |
Why?
| | RNA, Double-Stranded | 1 | 2025 | 57 | 0.230 |
Why?
| | Models, Biological | 4 | 2016 | 1783 | 0.230 |
Why?
| | Elasticity Imaging Techniques | 2 | 2016 | 60 | 0.230 |
Why?
| | Rabbits | 3 | 2022 | 794 | 0.230 |
Why?
| | Imaging, Three-Dimensional | 2 | 2019 | 580 | 0.220 |
Why?
| | Organ Size | 7 | 2013 | 477 | 0.220 |
Why?
| | Interferons | 1 | 2025 | 202 | 0.210 |
Why?
| | Algorithms | 3 | 2018 | 1704 | 0.210 |
Why?
| | Body Composition | 2 | 2021 | 684 | 0.210 |
Why?
| | Physical Examination | 1 | 2005 | 241 | 0.210 |
Why?
| | Models, Cardiovascular | 2 | 2016 | 198 | 0.200 |
Why?
| | Elastin | 2 | 2013 | 78 | 0.200 |
Why?
| | Femur Head | 1 | 2003 | 42 | 0.200 |
Why?
| | Pelvic Floor | 1 | 2023 | 22 | 0.200 |
Why?
| | Osteoclasts | 2 | 2020 | 52 | 0.200 |
Why?
| | Computer Simulation | 3 | 2016 | 978 | 0.200 |
Why?
| | Neurons | 1 | 2012 | 1590 | 0.200 |
Why?
| | Temperature | 2 | 2018 | 679 | 0.200 |
Why?
| | Stereolithography | 2 | 2021 | 8 | 0.190 |
Why?
| | Sheep | 3 | 2013 | 856 | 0.190 |
Why?
| | Disease Models, Animal | 9 | 2019 | 4295 | 0.190 |
Why?
| | Esters | 1 | 2022 | 76 | 0.190 |
Why?
| | Dinoprostone | 1 | 2022 | 191 | 0.190 |
Why?
| | Pressure | 4 | 2015 | 225 | 0.180 |
Why?
| | Sialoglycoproteins | 1 | 2002 | 159 | 0.180 |
Why?
| | RNA, Viral | 1 | 2025 | 656 | 0.180 |
Why?
| | RNA-Binding Proteins | 1 | 2025 | 422 | 0.180 |
Why?
| | Calcinosis | 1 | 2003 | 235 | 0.180 |
Why?
| | Biomimetics | 1 | 2021 | 44 | 0.180 |
Why?
| | Humans | 33 | 2025 | 137585 | 0.170 |
Why?
| | Glycation End Products, Advanced | 1 | 2021 | 82 | 0.170 |
Why?
| | Myosin Heavy Chains | 2 | 2013 | 192 | 0.170 |
Why?
| | Second Harmonic Generation Microscopy | 1 | 2020 | 3 | 0.170 |
Why?
| | Nursing Care | 1 | 2001 | 43 | 0.170 |
Why?
| | Quantitative Trait Loci | 1 | 2022 | 380 | 0.170 |
Why?
| | Bone Matrix | 2 | 2019 | 5 | 0.170 |
Why?
| | United States National Aeronautics and Space Administration | 1 | 2020 | 1 | 0.170 |
Why?
| | Spectrum Analysis, Raman | 1 | 2020 | 41 | 0.170 |
Why?
| | Weightlessness Simulation | 1 | 2020 | 7 | 0.170 |
Why?
| | Hardness Tests | 2 | 2010 | 2 | 0.170 |
Why?
| | Myostatin | 1 | 2020 | 25 | 0.170 |
Why?
| | Exercise Therapy | 1 | 2005 | 443 | 0.170 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2015 | 201 | 0.160 |
Why?
| | Aerospace Medicine | 1 | 2020 | 29 | 0.160 |
Why?
| | Salter-Harris Fractures | 1 | 2019 | 11 | 0.160 |
Why?
| | Fracture Healing | 1 | 2020 | 79 | 0.160 |
Why?
| | Scattering, Small Angle | 1 | 2019 | 26 | 0.160 |
Why?
| | Ligation | 2 | 2016 | 92 | 0.150 |
Why?
| | Oxidative Stress | 4 | 2018 | 1317 | 0.150 |
Why?
| | X-Ray Diffraction | 1 | 2019 | 104 | 0.150 |
Why?
| | Liver | 3 | 2017 | 1943 | 0.150 |
Why?
| | Disease Progression | 2 | 2016 | 2757 | 0.150 |
Why?
| | Multiple Myeloma | 1 | 2002 | 252 | 0.150 |
Why?
| | Body Weight | 5 | 2016 | 985 | 0.150 |
Why?
| | Lipid Bilayers | 1 | 2019 | 98 | 0.140 |
Why?
| | Polymers | 1 | 2022 | 490 | 0.140 |
Why?
| | Osteoprotegerin | 3 | 2015 | 24 | 0.140 |
Why?
| | Osteoarthritis, Knee | 1 | 2021 | 254 | 0.140 |
Why?
| | Reproducibility of Results | 2 | 2019 | 3284 | 0.140 |
Why?
| | Physical Exertion | 2 | 2012 | 215 | 0.140 |
Why?
| | Gene Expression | 4 | 2022 | 1502 | 0.140 |
Why?
| | Knee Joint | 1 | 2021 | 409 | 0.130 |
Why?
| | Adrenal Glands | 1 | 2017 | 78 | 0.130 |
Why?
| | Actins | 4 | 2020 | 416 | 0.130 |
Why?
| | Regression Analysis | 1 | 2019 | 1024 | 0.130 |
Why?
| | Rats | 5 | 2021 | 5647 | 0.130 |
Why?
| | Diffusion | 1 | 2016 | 116 | 0.130 |
Why?
| | Permeability | 1 | 2016 | 161 | 0.130 |
Why?
| | Femoral Neck Fractures | 1 | 2016 | 21 | 0.120 |
Why?
| | Genome-Wide Association Study | 1 | 2022 | 1431 | 0.120 |
Why?
| | Energy Intake | 1 | 1999 | 485 | 0.120 |
Why?
| | Sex Characteristics | 1 | 2021 | 762 | 0.120 |
Why?
| | Kidney Function Tests | 1 | 2016 | 160 | 0.120 |
Why?
| | Weight-Bearing | 3 | 2021 | 173 | 0.120 |
Why?
| | Hemostatic Techniques | 1 | 2015 | 46 | 0.120 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2015 | 41 | 0.120 |
Why?
| | Wound Healing | 1 | 2017 | 331 | 0.110 |
Why?
| | Tissue Preservation | 1 | 2014 | 12 | 0.110 |
Why?
| | Environment | 2 | 2014 | 358 | 0.110 |
Why?
| | Muscle Contraction | 2 | 2010 | 424 | 0.110 |
Why?
| | Veins | 1 | 2014 | 63 | 0.110 |
Why?
| | Models, Anatomic | 1 | 2014 | 93 | 0.110 |
Why?
| | Biocompatible Materials | 2 | 2016 | 425 | 0.110 |
Why?
| | Surface Properties | 3 | 2012 | 413 | 0.110 |
Why?
| | Phenotype | 2 | 2021 | 3196 | 0.110 |
Why?
| | SKP Cullin F-Box Protein Ligases | 1 | 2013 | 15 | 0.110 |
Why?
| | Thermometry | 1 | 2013 | 4 | 0.100 |
Why?
| | Tripartite Motif Proteins | 1 | 2013 | 41 | 0.100 |
Why?
| | Internet | 1 | 2018 | 655 | 0.100 |
Why?
| | Electrocoagulation | 1 | 2013 | 40 | 0.100 |
Why?
| | Sciatic Nerve | 2 | 2005 | 58 | 0.100 |
Why?
| | Olfactory Bulb | 1 | 2014 | 93 | 0.100 |
Why?
| | Compliance | 1 | 2012 | 49 | 0.100 |
Why?
| | Vascular Surgical Procedures | 1 | 2015 | 303 | 0.100 |
Why?
| | Recombinant Fusion Proteins | 1 | 2015 | 665 | 0.100 |
Why?
| | Eye | 1 | 2013 | 108 | 0.100 |
Why?
| | Tooth Calcification | 1 | 2012 | 3 | 0.100 |
Why?
| | Anthropology, Physical | 1 | 2012 | 28 | 0.100 |
Why?
| | Madagascar | 1 | 2012 | 48 | 0.100 |
Why?
| | Cell Death | 1 | 2014 | 374 | 0.100 |
Why?
| | Molar | 1 | 2012 | 49 | 0.100 |
Why?
| | Neurogenesis | 1 | 2014 | 149 | 0.100 |
Why?
| | Catheter Ablation | 1 | 2015 | 350 | 0.090 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2013 | 175 | 0.090 |
Why?
| | Reflex | 1 | 2012 | 68 | 0.090 |
Why?
| | Microscopy, Atomic Force | 1 | 2012 | 126 | 0.090 |
Why?
| | Proteomics | 1 | 2018 | 1111 | 0.090 |
Why?
| | Hepatitis A | 4 | 1982 | 26 | 0.090 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2013 | 218 | 0.090 |
Why?
| | Muscle Proteins | 1 | 2013 | 231 | 0.090 |
Why?
| | Viscoelastic Substances | 1 | 2011 | 10 | 0.090 |
Why?
| | Placental Insufficiency | 1 | 2013 | 116 | 0.090 |
Why?
| | Mitochondria | 2 | 2018 | 948 | 0.090 |
Why?
| | Primates | 1 | 2012 | 126 | 0.090 |
Why?
| | Video Recording | 1 | 2012 | 180 | 0.090 |
Why?
| | Case-Control Studies | 2 | 2013 | 3556 | 0.090 |
Why?
| | Ecology | 1 | 2012 | 118 | 0.090 |
Why?
| | Stress, Physiological | 2 | 2015 | 443 | 0.090 |
Why?
| | Cell Differentiation | 5 | 2020 | 1991 | 0.090 |
Why?
| | Polymethyl Methacrylate | 1 | 2010 | 22 | 0.090 |
Why?
| | Plastics | 1 | 2010 | 42 | 0.090 |
Why?
| | Radiography | 2 | 2011 | 822 | 0.090 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2013 | 611 | 0.090 |
Why?
| | Electromagnetic Fields | 1 | 2010 | 25 | 0.080 |
Why?
| | Analysis of Variance | 1 | 2013 | 1316 | 0.080 |
Why?
| | Reaction Time | 1 | 2012 | 412 | 0.080 |
Why?
| | Data Interpretation, Statistical | 1 | 2012 | 363 | 0.080 |
Why?
| | Action Potentials | 1 | 2013 | 493 | 0.080 |
Why?
| | Time Factors | 6 | 2013 | 6828 | 0.080 |
Why?
| | Cell Proliferation | 3 | 2012 | 2475 | 0.080 |
Why?
| | Gene Expression Profiling | 5 | 2017 | 1774 | 0.080 |
Why?
| | Myoglobin | 1 | 2009 | 13 | 0.080 |
Why?
| | Skin | 1 | 2014 | 752 | 0.080 |
Why?
| | Gestational Age | 1 | 2012 | 910 | 0.080 |
Why?
| | Middle Aged | 6 | 2020 | 33479 | 0.080 |
Why?
| | Granulocytes | 1 | 2008 | 80 | 0.070 |
Why?
| | Glycoproteins | 2 | 2001 | 342 | 0.070 |
Why?
| | Viscosity | 1 | 2009 | 92 | 0.070 |
Why?
| | Receptors, Glucocorticoid | 1 | 2010 | 155 | 0.070 |
Why?
| | Endothelial Cells | 2 | 2013 | 785 | 0.070 |
Why?
| | Immunity | 1 | 2009 | 143 | 0.070 |
Why?
| | Fetus | 1 | 2013 | 806 | 0.070 |
Why?
| | Mice, Inbred BALB C | 2 | 2020 | 1272 | 0.070 |
Why?
| | Nanotechnology | 1 | 2009 | 125 | 0.070 |
Why?
| | Lymphocyte Activation | 2 | 2009 | 1142 | 0.070 |
Why?
| | Interleukin-6 | 2 | 2022 | 778 | 0.070 |
Why?
| | Transcriptome | 3 | 2022 | 971 | 0.070 |
Why?
| | Sulfhydryl Compounds | 2 | 2022 | 189 | 0.070 |
Why?
| | Models, Animal | 2 | 2021 | 384 | 0.070 |
Why?
| | Bone Marrow Cells | 1 | 2008 | 316 | 0.070 |
Why?
| | Aged, 80 and over | 2 | 2013 | 7635 | 0.070 |
Why?
| | Regional Blood Flow | 1 | 2009 | 474 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2021 | 2531 | 0.070 |
Why?
| | Brain | 1 | 2018 | 2668 | 0.060 |
Why?
| | Infant | 8 | 2017 | 9465 | 0.060 |
Why?
| | Diaphyses | 2 | 2003 | 13 | 0.060 |
Why?
| | Metabolomics | 3 | 2017 | 678 | 0.060 |
Why?
| | Apoptosis | 1 | 2015 | 2553 | 0.060 |
Why?
| | Longitudinal Studies | 1 | 2013 | 2844 | 0.060 |
Why?
| | Interferon-Induced Helicase, IFIH1 | 1 | 2025 | 19 | 0.060 |
Why?
| | Muscular Disorders, Atrophic | 1 | 2005 | 4 | 0.060 |
Why?
| | Systems Integration | 1 | 2005 | 37 | 0.060 |
Why?
| | Men | 1 | 2005 | 21 | 0.060 |
Why?
| | Cell Survival | 3 | 2017 | 1120 | 0.060 |
Why?
| | Body Mass Index | 1 | 2013 | 2389 | 0.060 |
Why?
| | Metabolome | 2 | 2018 | 350 | 0.060 |
Why?
| | Hepatitis B | 4 | 1982 | 70 | 0.060 |
Why?
| | Pregnancy Complications | 1 | 2009 | 527 | 0.050 |
Why?
| | Infant, Newborn | 5 | 2013 | 6079 | 0.050 |
Why?
| | Cytokines | 2 | 2009 | 2085 | 0.050 |
Why?
| | Endothelium, Vascular | 1 | 2010 | 927 | 0.050 |
Why?
| | Hypertension | 1 | 2012 | 1295 | 0.050 |
Why?
| | In Vitro Techniques | 2 | 2015 | 1092 | 0.050 |
Why?
| | Fascia | 1 | 2023 | 17 | 0.050 |
Why?
| | Adult | 9 | 2013 | 37929 | 0.050 |
Why?
| | Polystyrenes | 1 | 2022 | 35 | 0.050 |
Why?
| | Humerus | 2 | 2001 | 39 | 0.050 |
Why?
| | United States | 1 | 2020 | 14841 | 0.050 |
Why?
| | Adolescent | 9 | 2017 | 21513 | 0.050 |
Why?
| | Lung | 1 | 2015 | 4060 | 0.050 |
Why?
| | Equipment Design | 2 | 2014 | 522 | 0.050 |
Why?
| | Myocardium | 2 | 1997 | 1002 | 0.050 |
Why?
| | Genes, MHC Class II | 1 | 2002 | 74 | 0.050 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2001 | 220 | 0.050 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2018 | 3715 | 0.050 |
Why?
| | RNA, Messenger | 5 | 2016 | 2833 | 0.040 |
Why?
| | Biomarkers | 4 | 2016 | 4149 | 0.040 |
Why?
| | Meniscus | 1 | 2021 | 22 | 0.040 |
Why?
| | Chondrogenesis | 1 | 2021 | 83 | 0.040 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2002 | 253 | 0.040 |
Why?
| | Mice, Knockout | 2 | 2025 | 3015 | 0.040 |
Why?
| | Guanidinoacetate N-Methyltransferase | 1 | 2020 | 5 | 0.040 |
Why?
| | Corticosterone | 2 | 2017 | 236 | 0.040 |
Why?
| | Biophysics | 1 | 2020 | 71 | 0.040 |
Why?
| | International Cooperation | 1 | 2001 | 198 | 0.040 |
Why?
| | T-Lymphocytes | 1 | 2008 | 1996 | 0.040 |
Why?
| | Cell Culture Techniques | 1 | 2022 | 363 | 0.040 |
Why?
| | Dietary Sucrose | 1 | 2000 | 49 | 0.040 |
Why?
| | Hyaluronic Acid | 1 | 2002 | 225 | 0.040 |
Why?
| | Bone Substitutes | 1 | 1999 | 28 | 0.040 |
Why?
| | Durapatite | 1 | 1999 | 37 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2021 | 455 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2021 | 247 | 0.040 |
Why?
| | Hydrostatic Pressure | 1 | 2019 | 31 | 0.040 |
Why?
| | Protein Isoforms | 1 | 2001 | 404 | 0.040 |
Why?
| | Extremities | 1 | 2020 | 131 | 0.040 |
Why?
| | Osseointegration | 1 | 1999 | 71 | 0.040 |
Why?
| | Forecasting | 1 | 2001 | 389 | 0.040 |
Why?
| | Lymphocyte Count | 2 | 2009 | 148 | 0.040 |
Why?
| | Proteoglycans | 1 | 2019 | 107 | 0.040 |
Why?
| | Intracellular Space | 1 | 2018 | 68 | 0.040 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 171 | 0.040 |
Why?
| | Signal Transduction | 3 | 2018 | 5079 | 0.040 |
Why?
| | Interprofessional Relations | 1 | 2001 | 283 | 0.040 |
Why?
| | Femur Neck | 1 | 2018 | 61 | 0.040 |
Why?
| | Gray Matter | 1 | 2018 | 80 | 0.040 |
Why?
| | Dietary Fats | 1 | 2000 | 304 | 0.030 |
Why?
| | Cell Cycle | 1 | 2001 | 601 | 0.030 |
Why?
| | Interleukin-1 | 1 | 2002 | 965 | 0.030 |
Why?
| | Receptors, Corticotropin | 1 | 2017 | 3 | 0.030 |
Why?
| | Osteoporotic Fractures | 1 | 2018 | 60 | 0.030 |
Why?
| | Sarcomeres | 1 | 1997 | 96 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2010 | 767 | 0.030 |
Why?
| | Polymerization | 1 | 2017 | 124 | 0.030 |
Why?
| | Catecholamines | 1 | 2017 | 98 | 0.030 |
Why?
| | Immune System Diseases | 1 | 2017 | 39 | 0.030 |
Why?
| | Glycolysis | 1 | 2018 | 321 | 0.030 |
Why?
| | White Matter | 1 | 2018 | 145 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2005 | 2828 | 0.030 |
Why?
| | Diabetes Complications | 1 | 2018 | 227 | 0.030 |
Why?
| | Young Adult | 1 | 2013 | 13209 | 0.030 |
Why?
| | Lipid Droplets | 1 | 2016 | 23 | 0.030 |
Why?
| | Hepatic Stellate Cells | 1 | 2016 | 13 | 0.030 |
Why?
| | PPAR alpha | 1 | 2016 | 58 | 0.030 |
Why?
| | Click Chemistry | 1 | 2016 | 49 | 0.030 |
Why?
| | Metabolic Diseases | 1 | 2017 | 108 | 0.030 |
Why?
| | Adhesiveness | 1 | 2015 | 20 | 0.030 |
Why?
| | RANK Ligand | 1 | 2015 | 29 | 0.030 |
Why?
| | Osteocalcin | 1 | 2015 | 37 | 0.030 |
Why?
| | Immunoglobulin G | 1 | 2020 | 893 | 0.030 |
Why?
| | Leukocytes | 1 | 2017 | 311 | 0.030 |
Why?
| | Systems Biology | 1 | 2016 | 67 | 0.030 |
Why?
| | DNA Primers | 2 | 2010 | 515 | 0.030 |
Why?
| | Phagocytosis | 1 | 2017 | 380 | 0.030 |
Why?
| | Light | 1 | 2017 | 381 | 0.030 |
Why?
| | Alkaline Phosphatase | 1 | 2015 | 148 | 0.030 |
Why?
| | Surgical Equipment | 1 | 2014 | 11 | 0.030 |
Why?
| | Bone Density Conservation Agents | 1 | 2015 | 80 | 0.030 |
Why?
| | Flow Cytometry | 2 | 2008 | 1178 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2017 | 622 | 0.030 |
Why?
| | Cell Adhesion Molecules | 1 | 2015 | 181 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2022 | 2426 | 0.030 |
Why?
| | DNA Fragmentation | 1 | 2013 | 41 | 0.030 |
Why?
| | Cell Adhesion | 1 | 2015 | 466 | 0.030 |
Why?
| | Shear Strength | 1 | 2013 | 67 | 0.030 |
Why?
| | Electric Impedance | 1 | 2013 | 107 | 0.030 |
Why?
| | Oncogene Proteins | 1 | 2013 | 59 | 0.030 |
Why?
| | Adaptation, Physiological | 2 | 2008 | 553 | 0.020 |
Why?
| | Hyalin | 1 | 2012 | 6 | 0.020 |
Why?
| | Child, Preschool | 7 | 2017 | 11074 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 1997 | 860 | 0.020 |
Why?
| | Base Sequence | 2 | 2010 | 2181 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2009 | 2057 | 0.020 |
Why?
| | Hepatitis, Viral, Human | 2 | 1982 | 25 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 1997 | 1457 | 0.020 |
Why?
| | Stem Cells | 1 | 2015 | 594 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor | 2 | 2001 | 164 | 0.020 |
Why?
| | Umbilical Veins | 1 | 2010 | 62 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2005 | 10811 | 0.020 |
Why?
| | Molecular Structure | 1 | 2011 | 489 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2013 | 1060 | 0.020 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2010 | 204 | 0.020 |
Why?
| | Fluorescent Antibody Technique, Indirect | 2 | 2001 | 51 | 0.020 |
Why?
| | Hemoglobin H | 1 | 1989 | 1 | 0.020 |
Why?
| | Thalassemia | 1 | 1989 | 7 | 0.020 |
Why?
| | Hemoglobins, Abnormal | 1 | 1989 | 11 | 0.020 |
Why?
| | Antigens, Ly | 1 | 2008 | 44 | 0.020 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2008 | 52 | 0.020 |
Why?
| | CD11b Antigen | 1 | 2008 | 61 | 0.020 |
Why?
| | Antigens, Differentiation | 1 | 2008 | 83 | 0.020 |
Why?
| | Hyaluronan Receptors | 1 | 2008 | 102 | 0.020 |
Why?
| | Antibodies, Viral | 3 | 1982 | 625 | 0.020 |
Why?
| | Leukocyte Count | 1 | 2009 | 329 | 0.020 |
Why?
| | Cell Count | 1 | 2008 | 324 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 2008 | 185 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 976 | 0.020 |
Why?
| | Aged | 4 | 2003 | 23961 | 0.020 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2008 | 141 | 0.020 |
Why?
| | Genetic Markers | 1 | 1989 | 344 | 0.020 |
Why?
| | Feeding Behavior | 1 | 2013 | 654 | 0.020 |
Why?
| | Child | 7 | 2017 | 21935 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2008 | 318 | 0.020 |
Why?
| | Microscopy, Fluorescence | 2 | 2001 | 402 | 0.020 |
Why?
| | Obesity | 1 | 2021 | 2992 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2010 | 545 | 0.020 |
Why?
| | Epidemiologic Methods | 3 | 1982 | 97 | 0.020 |
Why?
| | DNA Replication | 1 | 2008 | 238 | 0.020 |
Why?
| | Cell Lineage | 1 | 2008 | 350 | 0.020 |
Why?
| | Hepatitis B Surface Antigens | 3 | 1982 | 24 | 0.020 |
Why?
| | Transfection | 2 | 2001 | 945 | 0.020 |
Why?
| | Radiation Dosage | 1 | 2008 | 179 | 0.020 |
Why?
| | Up-Regulation | 1 | 2009 | 843 | 0.020 |
Why?
| | Blood Pressure | 1 | 2013 | 1786 | 0.010 |
Why?
| | Australia | 3 | 1982 | 315 | 0.010 |
Why?
| | Lipopolysaccharides | 1 | 2009 | 886 | 0.010 |
Why?
| | Killer Cells, Natural | 1 | 2008 | 449 | 0.010 |
Why?
| | Nerve Compression Syndromes | 1 | 2005 | 21 | 0.010 |
Why?
| | Nitric Oxide | 1 | 2010 | 915 | 0.010 |
Why?
| | Risk Factors | 1 | 2018 | 10388 | 0.010 |
Why?
| | Hepatovirus | 2 | 1982 | 3 | 0.010 |
Why?
| | Hepatitis B Core Antigens | 2 | 1981 | 3 | 0.010 |
Why?
| | Hepatitis B Antibodies | 2 | 1981 | 11 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 2 | 2000 | 2486 | 0.010 |
Why?
| | Pilot Projects | 1 | 2009 | 1710 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 2008 | 847 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2008 | 1396 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2010 | 4193 | 0.010 |
Why?
| | Cell Line | 1 | 2008 | 2847 | 0.010 |
Why?
| | Papua New Guinea | 1 | 1981 | 9 | 0.010 |
Why?
| | Nerve Crush | 1 | 2001 | 9 | 0.010 |
Why?
| | MyoD Protein | 1 | 2001 | 35 | 0.010 |
Why?
| | Altitude | 2 | 1981 | 488 | 0.010 |
Why?
| | Maxillofacial Prosthesis Implantation | 1 | 1999 | 3 | 0.010 |
Why?
| | Placebos | 1 | 2000 | 199 | 0.010 |
Why?
| | Antigens, Viral | 1 | 1980 | 178 | 0.010 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 1998 | 60 | 0.010 |
Why?
| | Disease Outbreaks | 1 | 1982 | 395 | 0.010 |
Why?
| | Myosin Light Chains | 1 | 1997 | 26 | 0.010 |
Why?
| | Troponin | 1 | 1997 | 50 | 0.010 |
Why?
| | Crosses, Genetic | 1 | 1997 | 137 | 0.010 |
Why?
| | Mice, Inbred DBA | 1 | 1997 | 200 | 0.010 |
Why?
| | Troponin T | 1 | 1997 | 65 | 0.010 |
Why?
| | Tropomyosin | 1 | 1997 | 14 | 0.010 |
Why?
| | Muscle Development | 1 | 1997 | 111 | 0.010 |
Why?
| | Molecular Weight | 1 | 1997 | 335 | 0.010 |
Why?
| | Cell Movement | 1 | 2001 | 967 | 0.010 |
Why?
| | Age Factors | 2 | 1981 | 3295 | 0.010 |
Why?
| | Animals, Newborn | 1 | 1997 | 844 | 0.010 |
Why?
| | Heart | 1 | 1997 | 655 | 0.010 |
Why?
| | Prospective Studies | 2 | 1981 | 7604 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2002 | 2691 | 0.010 |
Why?
| | Hepatitis C | 2 | 1982 | 271 | 0.000 |
Why?
| | Radioimmunoassay | 1 | 1982 | 173 | 0.000 |
Why?
| | New Guinea | 1 | 1981 | 4 | 0.000 |
Why?
| | Immunoglobulins | 1 | 1982 | 171 | 0.000 |
Why?
| | Injections | 1 | 1982 | 183 | 0.000 |
Why?
| | Family Health | 1 | 1982 | 196 | 0.000 |
Why?
| | Immunoglobulin M | 1 | 1982 | 289 | 0.000 |
Why?
| | Follow-Up Studies | 1 | 1982 | 5131 | 0.000 |
Why?
|
|
Ferguson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|